4//SEC Filing
Lefebvre Eric 4
Accession 0001746473-24-000119
CIK 0001746473other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:01 PM ET
Size
5.3 KB
Accession
0001746473-24-000119
Insider Transaction Report
Form 4
Lefebvre Eric
Chief Medical Officer
Transactions
- Award
Common Stock
2024-07-09+24,063→ 225,371 total
Footnotes (2)
- [F1]On July 28, 2022, the Reporting Person was granted 87,500 performance-vested stock units, the vesting of which were subject to the achievement of various pre-established performance criteria. On July 9, 2024, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the performance criteria tied to the company's total shareholder return relative to the Nasdaq Biotechnology Index, resulting in the vesting of 24,063 shares.
- [F2]Includes 1,488 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
Documents
Issuer
PLIANT THERAPEUTICS, INC.
CIK 0001746473
Entity typeother
Related Parties
1- filerCIK 0001614741
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 5:01 PM ET
- Size
- 5.3 KB